Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
+0.0000 (0.00%)
At close: Sep 25, 2024
Aridis Pharmaceuticals Revenue
Aridis Pharmaceuticals had revenue of $417.00K in the quarter ending September 30, 2023, with 4.51% growth. This brings the company's revenue in the last twelve months to $22.36M, up 680.42% year-over-year. In the year 2022, Aridis Pharmaceuticals had annual revenue of $3.09M with 101.37% growth.
Revenue (ttm)
22.36M
Revenue Growth
+680.42%
P/S Ratio
n/a
Revenue / Employee
604.30K
Employees
37
Market Cap
53.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Medexus Pharmaceuticals Inc. | 108.78M |